Brief: Botanix Pharmaceuticals Ltd Says Sofdra Gross Sales Reach A$25 Million Since January
07/07/2025 23:36
July 8 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX: SOFDRA GROSS SALES REACH A$25 MILLION SINCE JANUARY Further company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Receives Notice Of Allowance For Additional US Patent Covering Sofdra Drug Substance
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million